MEDIPHARM LABS CORP (LABS.CA) Stock Income Statement
TSX:LABS - CA58504D1006 - Common Stock
0.07 CAD
-0.01 (-12.5%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 44.45M | 41.96M | 33.06M | 22.10M | 21.70M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Cost Of Goods | 31.72M | 30.23M | 29.07M | 24.00M | 37.00M | |||
| Gross Profit | 12.74M | 11.73M | 3.99M | -1.90M | -15.20M | |||
| Operating Expenses | 23.00M | 23.37M | 23.60M | 27.40M | 35.80M | |||
| Research and Development | 285.00K | 235.00K | 209.00K | 1.00M | 1.40M | |||
| Selling, General, and Administrative Expenses | 22.67M | 22.77M | 22.87M | 23.90M | 29.80M | |||
| Operating Income | -10.26M | -11.64M | -19.61M | -29.20M | -51.10M | |||
| Interest Income/Expense | 95.00K | 170.00K | 19.00K | 200.00K | -4.10M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | 1.51M | 775.00K | 6.24M | -1.00M | 500.00K | |||
| Income Before Taxes | -8.66M | -10.69M | -13.36M | -30.00M | -54.70M | |||
| Income Tax | N/A | 0.00 | -276.00K | 0.00 | 100.00K | |||
| Net Income | -8.66M | -10.69M | -13.08M | -30.00M | -54.80M | |||
| EBITDA | -8.34M | -9.04M | -17.10M | -26.33M | -45.47M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.04 | -0.11 | -0.22 | |||
| Non GAAP EPS | -0.03 | -0.04 | -0.04 | -0.11 | -0.23 | |||
| Statistics | ||||||||
| Gross Profit Margin | 28.65% | 27.96% | 12.06% | -8.60% | -70.05% | |||
| Profit Margin | -19.47% | -25.49% | -39.57% | -135.75% | -252.53% | |||
| Operating Profit Margin | -23.08% | -27.74% | -59.32% | -132.13% | -235.48% | |||
All data in CAD